Elsevier

Pharmacological Research

Volume 44, Issue 3, September 2001, Pages 183-193
Pharmacological Research

Regular Article
Aescin: pharmacology, pharmacokinetics and therapeutic profile

https://doi.org/10.1006/phrs.2001.0847Get rights and content

Abstract

Aescin, the major active principle from Aesculus hippocastanum (Hippocastanaceae) the horse chestnut tree, has shown satisfactory evidence for a clinically significant activity in chronic venous insufficiency (CVI), haemorrhoids and post-operative oedema. In one controlled trial aescin was shown to be as effective as compression therapy as an alternative to medical treatment for CVI. The therapeutic benefit is well supported by a number of experimental investigations in different animal models, indicative of clearcut anti-oedematous, anti-inflammatory and venotonic properties, mainly related to the molecular mechanism of the agent, allowing improved entry of ions into channels, thus raising venous tension in both in vitro and in vivo conditions. Other mechanisms, i.e. release of PGF2from veins, antagonism to 5-HT and histamine, reduced catabolism of tissue mucopolysaccharides, further underline the wide ranging mechanisms of the therapeutic activity of aescin. The excellent tolerability of aescin in the clinic indicates this treatment is of definite clinical benefit in patients with clinical conditions resulting in CVI, haemorrhoids or peripheral oedema formation.

References (46)

  • D Lorenz et al.

    Das therapeutische wirksame Prinzip der Rosskastanie (Aesculus hippocastanum)

    Arzneim-Forsch

    (1960)
  • B Renger

    Quantitative densitometric HPTLC determination of triterpenic saponins (escin) in horse-chestnut extract

    J Planar Chromatogr

    (1990)
  • A Griffini et al.

    Liquid chromatography-thermospray mass spectrometry analysis of beta-escin

    Fitoterapia

    (1997)
  • PJ Pearson et al.

    Vasodilator and vasoconstrictor substances produced by the endothelium

    Rev Physiol Biochem Pharmacol

    (1993)
  • S Satoh et al.

    Augmented agonist-induced Ca++sensitization of coronary artery contraction in genetically hypertensive rats: evidence for altered signal transduction in the coronary smooth muscle cells

    J Clin Invest

    (1994)
  • D Panigati

    Farmacologia dell’escina, saponina dell’Aesculus hippocastanum L. Parte II. Farmacodinamica dell’escina. Capitolo II

    Boll Chim Farm

    (1992)
  • E Enghofer et al.

    Die antiexudative Wirkung von Rosskastaniensamen Extrakt

    Therapiewoche

    (1984)
  • G Bazzoni et al.

    Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation

    Haematologica

    (1991)
  • M Guillaume et al.

    Venotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract

    Arzneim-Forsch

    (1994)
  • H Bisler et al.

    Wirkung von Rosskastaniensamenextrakt auf die transkapillaere Filtration bei chronischer venoeser Insuffizienz

    Dtsch Med Wochenschr

    (1986)
  • RM Facino et al.

    Anti-elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: factors contributing to their efficacy in the treatment of venous insufficiency

    Arch Pharmacol

    (1995)
  • D Panigati

    Farmacologia dell’escina, saponina dell’Aesculus hippocastanum L. Parte II. Farmacologia dell’escina. Capitolo I

    Boll Chim Farm

    (1992)
  • Cited by (362)

    View all citing articles on Scopus
    View full text